Arrhythmogenic and inotropic effects of interferon investigated in perfused and in vivo rat hearts influences of cardiac hypertrophy and isoproterenol

Keita Odashiro, Shin ichi Hiramatsu, Nobuhito Yanagi, Takeshi Arita, Toru Maruyama, Yoshikazu Kaji, Mine Harada

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Although the arrhythmogenic effects of interferon (IF) have been reported in clinical practice, the experimental data are limited. Therefore, these effects were investigated in in vivo and Langendorff-perfusion studies using 3 different groups of rats (ie, control, aorta-banded, and deoxycorticosterone acetate (DOCA)-salt hypertension groups) in the presence or absence of isoproterenol. In the perfusion study, human recombinant IF-α (≤15,000 U/ml) alone induced irreversible atrioventricular blockade in all groups, whereas this agent (≤1,500 U/ml) caused negative inotropism and ventricular tachyarrhythmias (arrhythmic score greater in the order of DOCA-salt>aorta-banded = control group) in the preparations pretreated with isoproterenol (10-9 mol/L). In an in vivo study, IF-α (6x106 U/kg) resulted in ventricular tachyarrhythmias only in the presence of isoproterenol (10 mg/kg), as in the perfusion study (arrhythmic score; DOCA-salt>aorta-banded>control). In conclusion, the arrhythmogenesis of IF-α is potentiated in pathophysiological conditions such as cardiac hypertrophy or elevated sympathetic activity.

Original languageEnglish
Pages (from-to)1161-1167
Number of pages7
JournalCirculation Journal
Volume66
Issue number12
DOIs
Publication statusPublished - Dec 1 2002

Fingerprint

Cardiomegaly
Isoproterenol
Desoxycorticosterone
Interferons
Aorta
Acetates
Perfusion
Salts
Tachycardia
Muscle Contraction
Hypertension
Control Groups

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Arrhythmogenic and inotropic effects of interferon investigated in perfused and in vivo rat hearts influences of cardiac hypertrophy and isoproterenol. / Odashiro, Keita; Hiramatsu, Shin ichi; Yanagi, Nobuhito; Arita, Takeshi; Maruyama, Toru; Kaji, Yoshikazu; Harada, Mine.

In: Circulation Journal, Vol. 66, No. 12, 01.12.2002, p. 1161-1167.

Research output: Contribution to journalArticle

Odashiro, Keita ; Hiramatsu, Shin ichi ; Yanagi, Nobuhito ; Arita, Takeshi ; Maruyama, Toru ; Kaji, Yoshikazu ; Harada, Mine. / Arrhythmogenic and inotropic effects of interferon investigated in perfused and in vivo rat hearts influences of cardiac hypertrophy and isoproterenol. In: Circulation Journal. 2002 ; Vol. 66, No. 12. pp. 1161-1167.
@article{feb53c993f5b42fab28025b429d3c84c,
title = "Arrhythmogenic and inotropic effects of interferon investigated in perfused and in vivo rat hearts influences of cardiac hypertrophy and isoproterenol",
abstract = "Although the arrhythmogenic effects of interferon (IF) have been reported in clinical practice, the experimental data are limited. Therefore, these effects were investigated in in vivo and Langendorff-perfusion studies using 3 different groups of rats (ie, control, aorta-banded, and deoxycorticosterone acetate (DOCA)-salt hypertension groups) in the presence or absence of isoproterenol. In the perfusion study, human recombinant IF-α (≤15,000 U/ml) alone induced irreversible atrioventricular blockade in all groups, whereas this agent (≤1,500 U/ml) caused negative inotropism and ventricular tachyarrhythmias (arrhythmic score greater in the order of DOCA-salt>aorta-banded = control group) in the preparations pretreated with isoproterenol (10-9 mol/L). In an in vivo study, IF-α (6x106 U/kg) resulted in ventricular tachyarrhythmias only in the presence of isoproterenol (10 mg/kg), as in the perfusion study (arrhythmic score; DOCA-salt>aorta-banded>control). In conclusion, the arrhythmogenesis of IF-α is potentiated in pathophysiological conditions such as cardiac hypertrophy or elevated sympathetic activity.",
author = "Keita Odashiro and Hiramatsu, {Shin ichi} and Nobuhito Yanagi and Takeshi Arita and Toru Maruyama and Yoshikazu Kaji and Mine Harada",
year = "2002",
month = "12",
day = "1",
doi = "10.1253/circj.66.1161",
language = "English",
volume = "66",
pages = "1161--1167",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "12",

}

TY - JOUR

T1 - Arrhythmogenic and inotropic effects of interferon investigated in perfused and in vivo rat hearts influences of cardiac hypertrophy and isoproterenol

AU - Odashiro, Keita

AU - Hiramatsu, Shin ichi

AU - Yanagi, Nobuhito

AU - Arita, Takeshi

AU - Maruyama, Toru

AU - Kaji, Yoshikazu

AU - Harada, Mine

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Although the arrhythmogenic effects of interferon (IF) have been reported in clinical practice, the experimental data are limited. Therefore, these effects were investigated in in vivo and Langendorff-perfusion studies using 3 different groups of rats (ie, control, aorta-banded, and deoxycorticosterone acetate (DOCA)-salt hypertension groups) in the presence or absence of isoproterenol. In the perfusion study, human recombinant IF-α (≤15,000 U/ml) alone induced irreversible atrioventricular blockade in all groups, whereas this agent (≤1,500 U/ml) caused negative inotropism and ventricular tachyarrhythmias (arrhythmic score greater in the order of DOCA-salt>aorta-banded = control group) in the preparations pretreated with isoproterenol (10-9 mol/L). In an in vivo study, IF-α (6x106 U/kg) resulted in ventricular tachyarrhythmias only in the presence of isoproterenol (10 mg/kg), as in the perfusion study (arrhythmic score; DOCA-salt>aorta-banded>control). In conclusion, the arrhythmogenesis of IF-α is potentiated in pathophysiological conditions such as cardiac hypertrophy or elevated sympathetic activity.

AB - Although the arrhythmogenic effects of interferon (IF) have been reported in clinical practice, the experimental data are limited. Therefore, these effects were investigated in in vivo and Langendorff-perfusion studies using 3 different groups of rats (ie, control, aorta-banded, and deoxycorticosterone acetate (DOCA)-salt hypertension groups) in the presence or absence of isoproterenol. In the perfusion study, human recombinant IF-α (≤15,000 U/ml) alone induced irreversible atrioventricular blockade in all groups, whereas this agent (≤1,500 U/ml) caused negative inotropism and ventricular tachyarrhythmias (arrhythmic score greater in the order of DOCA-salt>aorta-banded = control group) in the preparations pretreated with isoproterenol (10-9 mol/L). In an in vivo study, IF-α (6x106 U/kg) resulted in ventricular tachyarrhythmias only in the presence of isoproterenol (10 mg/kg), as in the perfusion study (arrhythmic score; DOCA-salt>aorta-banded>control). In conclusion, the arrhythmogenesis of IF-α is potentiated in pathophysiological conditions such as cardiac hypertrophy or elevated sympathetic activity.

UR - http://www.scopus.com/inward/record.url?scp=0036895437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036895437&partnerID=8YFLogxK

U2 - 10.1253/circj.66.1161

DO - 10.1253/circj.66.1161

M3 - Article

VL - 66

SP - 1161

EP - 1167

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 12

ER -